Intranasal corticosteroid therapy and bronchial hyperresponsiveness in the unified airway.
Currie
Graeme P
GP
Lee
Daniel K C
DK
D000485:Allergens / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D001798:Blood Proteins / Q000378:metabolism; D001980:Bronchi / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D016535:Bronchial Hyperreactivity / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D047091:Eosinophil Granule Proteins; D004804:Eosinophils / Q000378:metabolism; D005541:Forced Expiratory Volume / Q000187:drug effects; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D011058:Pollen / Q000009:adverse effects; D012260:Ribonucleases / Q000378:metabolism; D012621:Seasons; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*
D000485:Allergens; D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D005938:Glucocorticoids; D012260:Ribonucleases; D014222:Triamcinolone Acetonide